TransMedics Group, Inc. (TMDX)
TransMedics Group Market Cap : 3.348B for Nov. 18, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 18, 2026 | 3.348B |
| November 17, 2026 | 3.261B |
| November 16, 2026 | 3.202B |
| November 13, 2026 | 3.173B |
| November 12, 2026 | 3.194B |
| November 11, 2026 | 3.195B |
| November 10, 2026 | 3.158B |
| November 09, 2026 | 3.257B |
| November 06, 2026 | 3.064B |
| November 05, 2026 | 2.395B |
| November 04, 2026 | 2.526B |
| November 03, 2026 | 2.338B |
| November 02, 2026 | 2.309B |
| October 30, 2026 | 2.285B |
| October 29, 2026 | 2.324B |
| October 28, 2026 | 2.317B |
| October 27, 2026 | 2.415B |
| October 26, 2026 | 2.446B |
| October 23, 2026 | 2.450B |
| October 22, 2026 | 2.495B |
| October 21, 2026 | 2.507B |
| October 20, 2026 | 2.589B |
| October 19, 2026 | 2.479B |
| October 16, 2026 | 2.451B |
| October 15, 2026 | 2.650B |
| Date | Value |
|---|---|
| October 14, 2026 | 2.615B |
| October 13, 2026 | 2.740B |
| October 12, 2026 | 2.707B |
| October 09, 2026 | 2.697B |
| October 08, 2026 | 2.736B |
| October 07, 2026 | 2.807B |
| October 06, 2026 | 2.780B |
| October 05, 2026 | 2.874B |
| October 02, 2026 | 2.763B |
| October 01, 2026 | 2.723B |
| September 30, 2026 | 2.890B |
| September 29, 2026 | 2.911B |
| September 28, 2026 | 2.865B |
| September 25, 2026 | 2.954B |
| September 24, 2026 | 2.905B |
| September 23, 2026 | 3.013B |
| September 22, 2026 | 3.050B |
| September 21, 2026 | 3.023B |
| September 18, 2026 | 2.993B |
| September 17, 2026 | 3.001B |
| September 16, 2026 | 3.032B |
| September 15, 2026 | 3.051B |
| September 14, 2026 | 2.973B |
| September 11, 2026 | 2.846B |
| September 10, 2026 | 2.945B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Boston Scientific Corp. | 63.25B |
| Insulet Corp. | 9.710B |
| Abbott Laboratories | 180.95B |
| Baxter International, Inc. | 13.53B |
| Becton, Dickinson & Co. | 58.86B |
Market Cap Related Metrics
| PE Ratio | 26.44 |
| PS Ratio | 5.257 |
| PEG Ratio | 0.5589 |
| Price to Book Value | 6.080 |
| Price to Free Cash Flow | 85.58 |
| Price | 96.43 |
| Earnings Yield | 3.78% |
| PEGY Ratio | 0.5589 |
| Operating PE Ratio | 43.91 |
| Normalized PE Ratio | 26.36 |